Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF 750

Copy Product Info
😃Good
Catalog No. T16515Cas No. 959151-50-9
Alias ZINC27647189, UNII-7756CPP14K, PF-750

PF 750 (ZINC27647189) is a selective and covalent inhibitor of FAAH. PF 750 shows IC50s varying from 16.2 to 595 nM in different incubation times.

PF 750

PF 750

Copy Product Info
😃Good
Purity: 99.87%
Catalog No. T16515Alias ZINC27647189, UNII-7756CPP14K, PF-750Cas No. 959151-50-9
PF 750 (ZINC27647189) is a selective and covalent inhibitor of FAAH. PF 750 shows IC50s varying from 16.2 to 595 nM in different incubation times.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$33-In Stock
5 mg$56-In Stock
10 mg$89-In Stock
25 mg$197-In Stock
50 mg$313-In Stock
100 mg$467-In Stock
200 mg$669-In Stock
500 mg$987-In Stock
1 mL x 10 mM (in DMSO)$62-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.87%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PF 750 AI Summary
PF 750 is a potent inhibitor of fatty acid amide hydrolase (FAAH), exhibiting an IC50 value of 16.2 nM. It demonstrates selectivity towards human FAAH over rat FAAH with a Kinact/Ki ratio selectivity of 8.0. Additionally, it effectively inhibits human recombinant FAAH, showing varying inhibition potency across different assay conditions, including both reversible and irreversible inhibition profiles. Besides its FAAH inhibitory activity, PF 750 shows notable antiviral activity by significantly reducing SARS-CoV-2 induced cytotoxicity in Caco-2 and VERO-6 cells at a concentration of 10 µM, and it also inhibits SARS-CoV-2 3CL-Pro protease to a lesser extent. Moreover, PF 750 inhibits human HDAC6 by 27.72% in enzymatic assays using commercial peptide substrates. These multifaceted activities underscore its potential as a therapeutic agent targeting FAAH and exhibiting some antiviral properties..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PF 750 (ZINC27647189) is a selective and covalent inhibitor of FAAH. PF 750 shows IC50s varying from 16.2 to 595 nM in different incubation times.
Targets&IC50
FAAH:16.2-595 nM
SynonymsZINC27647189, UNII-7756CPP14K, PF-750
Chemical Properties
Molecular Weight345.44
FormulaC22H23N3O
Cas No.959151-50-9
SmilesO=C(Nc1ccccc1)N1CCC(Cc2cnc3ccccc3c2)CC1
Relative Density.1.226 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 90 mg/mL (260.54 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8949 mL14.4743 mL28.9486 mL144.7429 mL
5 mM0.5790 mL2.8949 mL5.7897 mL28.9486 mL
10 mM0.2895 mL1.4474 mL2.8949 mL14.4743 mL
20 mM0.1447 mL0.7237 mL1.4474 mL7.2371 mL
50 mM0.0579 mL0.2895 mL0.5790 mL2.8949 mL
100 mM0.0289 mL0.1447 mL0.2895 mL1.4474 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF 750 | purchase PF 750 | PF 750 cost | order PF 750 | PF 750 chemical structure | PF 750 formula | PF 750 molecular weight